Home » Newsletters » BioWorld Science

BioWorld Science

March 17, 2014

View Archived Issues

BioMarin Pharmaceutical designs new agent for mucopolysaccharidosis type IIIB

Novel proteasome inhibitor discovered by Vivolux

Gliknik patents novel stradobodies

U.S. researchers prepare new MAbs for diagnostic and treatment of cancer

Japanese investigators isolate new agents for cancer

Islet Sciences to acquire BHV Pharma, remogliflozin etabonate

Researchers at Chugai Pharmaceutical present novel antibodies

Tesaro and AnaptysBio establish immuno-oncology antibody collaboration

Early Access to Medicines and Promising Innovative Medicine schemes to be introduced in the U.K.

Dose-related efficacy seen with house dust mite allergy immunotherapy tablet MK-8237

Potent, pangenomic activity for ABT-493 and ABT-530 reported

Regenerative Sciences' Regenexx-SD stem cell therapy studied for knee osteoarthritis

Results from phase III COPD studies comparing Anoro Ellipta with Advair Diskus and Seretide Diskus

Japanese approval for Poteligeo in PTCL and CTCL

GLPG-0187 shows a favorable toxicity profile in phase I trials in patients with solid tumors

Edison's EPI-743 begins trial in Pearson syndrome, receives fast track designation

Primary endpoint met in POISE trial of obeticholic acid in primary biliary cirrhosis

FDA approves intravenous formulation of Noxafil

FDA approves Eliquis to prevent DVT following hip or knee replacement surgery

Daiichi Sankyo seeks Japanese approval of methylene blue for methemoglobinemia

VG Life Sciences gives update on phase I study of HCQ in combination with sorafenib

Novel spirocyclic diamine derivatives with activity in animal models of CKD

Novartis' Afinitor approved in additional indication in Japan

Fujifilm initiates Japanese phase I study of a radiopharmaceutical diagnostic for prostate cancer

GW Pharmaceuticals updates progress of cannabinoid programs

New grant supports Karo Bio's preclinical development of ER-beta agonist

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...